In this study, blockade of ASCT2 with C118P resulted in attenuated cancer cell growth and proliferation, increased cell apoptosis, and G2/M cell cycle arrest, which collectively contributed to the antitumour response of C118P in vitro and in vivo. Here, SLC1A5 is linked to cancer.